These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19911773)

  • 1. Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
    Genet C; Strehle A; Schmidt C; Boudjelal G; Lobstein A; Schoonjans K; Souchet M; Auwerx J; Saladin R; Wagner A
    J Med Chem; 2010 Jan; 53(1):178-90. PubMed ID: 19911773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay.
    Lo SH; Cheng KC; Li YX; Chang CH; Cheng JT; Lee KS
    Drug Des Devel Ther; 2016; 10():2669-76. PubMed ID: 27578964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy.
    Wang XY; Zhang SY; Li J; Liu HN; Xie X; Nan FJ
    Acta Pharmacol Sin; 2014 Nov; 35(11):1463-72. PubMed ID: 25283506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining the TGR5 triterpenoid binding pocket at the C-3 position.
    Genet C; Schmidt C; Strehle A; Schoonjans K; Auwerx J; Saladin R; Wagner A
    ChemMedChem; 2010 Dec; 5(12):1983-8. PubMed ID: 20979081
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
    Li Z; Huang J; Wang F; Li W; Wu X; Zhao C; Zhao J; Wei H; Wu Z; Qian M; Sun P; He L; Jin Y; Tang J; Qiu W; Siwko S; Liu M; Luo J; Xiao J
    J Bone Miner Res; 2019 Apr; 34(4):765-776. PubMed ID: 30536462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
    Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
    J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats.
    Lo SH; Li Y; Cheng KC; Niu CS; Cheng JT; Niu HS
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1097-1104. PubMed ID: 28756460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5
    Yun Y; Zhang C; Guo S; Liang X; Lan Y; Wang M; Zhuo N; Yin J; Liu H; Gu M; Li J; Xie X; Nan F
    J Med Chem; 2021 Aug; 64(16):12181-12199. PubMed ID: 34406006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial properties of amine- and guanidine-functionalized derivatives of betulinic, ursolic and oleanolic acids: Synthesis and structure/activity evaluation.
    Spivak AY; Khalitova RR; Nedopekina DA; Gubaidullin RR
    Steroids; 2020 Feb; 154():108530. PubMed ID: 31678136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
    Shi W; Tang N; Yan WD
    J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.
    Rizzo G; Passeri D; De Franco F; Ciaccioli G; Donadio L; Rizzo G; Orlandi S; Sadeghpour B; Wang XX; Jiang T; Levi M; Pruzanski M; Adorini L
    Mol Pharmacol; 2010 Oct; 78(4):617-30. PubMed ID: 20631053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid and oleanolic acid, natural pentacyclic triterpenoids, interfere with N-linked glycan modifications to intercellular adhesion molecule-1, but not its intracellular transport to the cell surface.
    Hiramatsu R; Fukuhara S; Mitsuda S; Yokomichi T; Kataoka T
    Eur J Pharmacol; 2015 Nov; 767():126-34. PubMed ID: 26460147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals.
    Li Y; Cheng KC; Niu CS; Lo SH; Cheng JT; Niu HS
    Drug Des Devel Ther; 2017; 11():1127-1134. PubMed ID: 28435224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
    Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
    Pellicciari R; Sato H; Gioiello A; Costantino G; Macchiarulo A; Sadeghpour BM; Giorgi G; Schoonjans K; Auwerx J
    J Med Chem; 2007 Sep; 50(18):4265-8. PubMed ID: 17685603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the study of structural modifications and biological activities of betulinic acids].
    Lan P; Zhang DM; Chen WM; Ye WC
    Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ursolic and betulinic derivatives as potential cytotoxic agents.
    Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
    J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.
    Bi Y; Xu J; Wu X; Ye W; Yuan S; Zhang L
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1475-8. PubMed ID: 17275295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.
    McMillin M; Frampton G; Tobin R; Dusio G; Smith J; Shin H; Newell-Rogers K; Grant S; DeMorrow S
    J Neurochem; 2015 Nov; 135(3):565-76. PubMed ID: 26179031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids.
    Tanachatchairatana T; Bremner JB; Chokchaisiri R; Suksamrarn A
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):194-8. PubMed ID: 18239308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.